Picture of Lunit logo

328130 — Lunit News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Brief: Lunit Shows Promise Of AI In Predicting Immunotherapy Response For Rare Cancer Patients At SITC 2024

Nov 8 (Reuters) - Lunit Inc  328130.KQ :
    * LUNIT SHOWS PROMISE OF AI IN PREDICTING IMMUNOTHERAPY
RESPONSE
FOR RARE CANCER PATIENTS AT SITC 2024

Source text:  ID:nPn2w8ZpDa 
Further company coverage:  328130.KQ 

 (Reuters.Briefs@thomsonreuters.com)

Recent news on Lunit

See all news